sur AI/ML Innovations Inc. (CVE:AIML)
AIML's NeuralCloud and Toronto Heart Centre Test AI-Enhanced Holter ECG Reporting
AI/ML Innovations Inc. has announced a collaborative pilot program between its subsidiary, NeuralCloud Solutions, and the Toronto Heart Centre. The initiative will assess the efficacy of CardioYield™, an AI-powered Holter ECG analysis and reporting tool.
CardioYield™ utilizes MaxYield™, a signal-processing platform, to improve report turnaround times and technician efficiency at the Toronto Heart Centre. This facility, comprising over 20 cardiologists, offers advanced cardiovascular services in the community.
The study involves direct comparisons with current industry-standard software, focusing on time savings, throughput, and analysis quality. The outcome aims to showcase the potential of AI to enhance diagnostic reliability and workflow efficiency in clinical settings.
Experts from both parties, including Dr. Chi Ming Chow and Paul Duffy, express optimism about the program's ability to transform Holter data processing. This partnership highlights an important step in leveraging AI for improved healthcare outcomes.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AI/ML Innovations Inc.